申请人:FETTER Jozsef
公开号:US20120252784A1
公开(公告)日:2012-10-04
Novel 2,3,4-benzothiadiazepines-2,2-dioxides and processes for the preparation thereof are disclosed. The compounds influence the central nervous system and may be used to treat or prevent Alzheimer's disease, Parkinson's disease or Huntington's disease, senile dementia not of the Alzheimer's type, vascular dementia, post-stroke dementia, Korsakoff's syndrome, Down's syndrome, schizophrenia, panic disorder, post-traumatic stress disorder, anxiety or depression.
揭示了新型2,3,4-苯并噻二唑二氧化物及其制备方法。这些化合物影响中枢神经系统,可用于治疗或预防阿尔茨海默病、帕金森病或亨廷顿病、老年性非阿尔茨海默型痴呆、血管性痴呆、中风后痴呆、科萨科夫综合征、唐氏综合征、精神分裂症、恐慌症、创伤后应激障碍、焦虑或抑郁症。